| Primary |
| Acne |
41.9% |
| Drug Use For Unknown Indication |
27.5% |
| Product Used For Unknown Indication |
5.0% |
| Vasculitis |
4.1% |
| Endocarditis |
2.7% |
| Infection |
2.3% |
| Urethritis |
2.3% |
| Rosacea |
1.8% |
| Cough |
1.4% |
| Mental Disorder |
1.4% |
| Pulmonary Air Leakage |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Anxiety |
0.9% |
| Arthropod Bite |
0.9% |
| Contraception |
0.9% |
| Eye Infection Bacterial |
0.9% |
| Lyme Borreliosis |
0.9% |
| Multiple Sclerosis |
0.9% |
| Pyrexia |
0.9% |
| Shunt Malfunction |
0.9% |
|
| Transaminases Increased |
21.6% |
| Polyarteritis Nodosa |
9.0% |
| Autoimmune Disorder |
6.3% |
| Vasculitis |
6.3% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.4% |
| Urticaria |
5.4% |
| Pyrexia |
4.5% |
| Thyroid Disorder |
4.5% |
| Vomiting |
4.5% |
| Weight Decreased |
4.5% |
| Benign Intracranial Hypertension |
3.6% |
| Blood Creatinine Increased |
3.6% |
| Splenomegaly |
3.6% |
| Acute Febrile Neutrophilic Dermatosis |
2.7% |
| Intracranial Pressure Increased |
2.7% |
| Photophobia |
2.7% |
| Serum Sickness-like Reaction |
2.7% |
| Skin Hyperpigmentation |
2.7% |
| Cardiac Arrest |
1.8% |
| Depersonalisation |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
20.4% |
| Pneumonia |
12.2% |
| Pyrexia |
11.5% |
| Rheumatoid Arthritis |
5.9% |
| Drug Use For Unknown Indication |
5.1% |
| Colorectal Cancer |
4.6% |
| Cough |
4.3% |
| Prophylaxis |
4.3% |
| Nasopharyngitis |
4.1% |
| Interstitial Lung Disease |
3.3% |
| Urinary Tract Infection |
3.3% |
| Acne |
3.1% |
| Infective Tenosynovitis |
3.1% |
| Constipation |
2.5% |
| Infection |
2.5% |
| C-reactive Protein Increased |
2.0% |
| Disseminated Intravascular Coagulation |
2.0% |
| Malignant Peritoneal Neoplasm |
2.0% |
| Trigeminal Neuralgia |
2.0% |
| Bronchitis |
1.8% |
|
| Eosinophilic Pneumonia |
14.5% |
| Anaphylactic Shock |
7.3% |
| Interstitial Lung Disease |
7.3% |
| Renal Tubular Disorder |
7.3% |
| Uveitis |
7.3% |
| Toxic Skin Eruption |
5.5% |
| Trichosporon Infection |
5.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.6% |
| Erythema Multiforme |
3.6% |
| Fatigue |
3.6% |
| Prothrombin Time Prolonged |
3.6% |
| Pseudomembranous Colitis |
3.6% |
| Pyrexia |
3.6% |
| Stevens-johnson Syndrome |
3.6% |
| Thrombocytopenia |
3.6% |
| Toxic Epidermal Necrolysis |
3.6% |
| Viral Infection |
3.6% |
| Vulvovaginal Discomfort |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Aspartate Aminotransferase Increased |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.7% |
| Prophylaxis |
12.9% |
| Drug Use For Unknown Indication |
9.4% |
| Infection Prophylaxis |
8.2% |
| Rheumatoid Arthritis |
6.8% |
| Colorectal Cancer |
3.6% |
| Prophylaxis Against Graft Versus Host Disease |
3.6% |
| Bone Marrow Conditioning Regimen |
3.5% |
| Pneumonia |
2.9% |
| Hypertension |
2.5% |
| Premedication |
2.4% |
| Graft Versus Host Disease |
2.4% |
| Infection |
2.2% |
| Diabetes Mellitus |
2.0% |
| Antifungal Prophylaxis |
1.8% |
| Aplastic Anaemia |
1.7% |
| Postoperative Care |
1.7% |
| Acne |
1.6% |
| Constipation |
1.6% |
| Acute Lymphocytic Leukaemia |
1.5% |
|
| Pneumonia |
8.7% |
| White Blood Cell Count Decreased |
8.7% |
| Sepsis |
7.2% |
| Vasculitis |
7.2% |
| Pyrexia |
6.5% |
| Pulmonary Alveolar Haemorrhage |
5.8% |
| Septic Shock |
5.8% |
| Ventricular Extrasystoles |
5.8% |
| Scleroderma |
5.1% |
| Rhabdomyolysis |
4.3% |
| Vomiting |
4.3% |
| Weight Increased |
4.3% |
| White Blood Cell Count Increased |
4.3% |
| Interstitial Lung Disease |
3.6% |
| Stomatitis |
3.6% |
| Alopecia |
2.9% |
| Malaise |
2.9% |
| Neuropathy Peripheral |
2.9% |
| Pain |
2.9% |
| Rash |
2.9% |
|
| Interacting |
| Acne |
40.0% |
| Infection Prophylaxis |
40.0% |
| Epilepsy |
20.0% |
|
| Hyperbilirubinaemia |
50.0% |
| Drug Interaction |
25.0% |
| Sunburn |
25.0% |
|
